Qorium is a technology company.
Qorium has raised $28.0M across 2 funding rounds.
Qorium has raised $28.0M in total across 2 funding rounds.
Qorium has raised $28.0M in total across 2 funding rounds.
Qorium's investors include Brightlands Venture Partners, Soffinova Partners.
Qorium is a Dutch biotechnology company founded in 2014 that produces premium, cell-cultured leather from animal collagen cells, eliminating the need for livestock farming and traditional animal hides.[1][2][3] It serves the fashion, luxury goods, automotive, furniture, and premium footwear industries by providing sustainable leather that is uniform, tunable, and integrates into existing tanning processes, solving environmental issues like high water use, energy consumption, methane emissions, and material waste associated with conventional leather.[2][3][4] With €22 million in recent Series A funding (building on €8 million seed), Qorium is scaling production via new bioreactors in Maastricht, securing commercial partnerships, and demonstrating strong growth momentum toward commercialization.[3][5]
Qorium was co-founded in 2014 by Rutger Ploem, a sixth-generation tanner with 30 years of leather industry experience; Stef Kranendijk; and Professor Dr. Mark Post, a biotech pioneer, who recognized the potential of cell-cultured leather to address traditional production's ethical and environmental flaws.[2] The idea emerged from Ploem's passion for leather combined with frustration over its impacts—such as animal slaughter, pollution, and inconsistency—leading him to collaborate with Post on biotechnology solutions.[2] Early traction included developing a proof-of-concept 35x35cm leather sample, €8 million in seed funding (including €2.6 million in 2021 and more in 2024), and progression to pilot production, culminating in the €22 million Series A in 2025 from investors like Invest-NL, LIOF, Brightlands Venture Partners, Sofinnova Partners, and high-net-worth individuals.[3][5]
Qorium rides the wave of cultivated biotechnology and sustainable materials, addressing the $100+ billion leather market's push for alternatives amid rising demand for ethical, low-impact luxury goods driven by consumer and regulatory pressures (e.g., EU sustainability mandates).[1][3] Timing is ideal as cultivated leather market projections surge with scalable tech maturity, outpacing plant-based or mycelium rivals like MycoWorks or PEELSPHERE by offering "real" animal-derived collagen without farming.[1][4] Favorable forces include biotech cost reductions, bioreactor advancements, and brand commitments to net-zero (e.g., fashion's Scope 3 emissions focus), positioning Qorium to disrupt livestock-dependent supply chains and influence ecosystem shifts toward biofabrication in materials science.[2][3][5]
Qorium is primed for explosive growth, leveraging its €30+ million total funding to ramp bioreactor production, expand partnerships, and launch commercial volumes in luxury automotive and fashion by 2026-2027.[3][5] Key trends like AI-optimized cell culturing, circular bioeconomies, and stricter global emissions rules will accelerate adoption, potentially capturing 10-20% of premium leather segments as costs drop below traditional methods. Its influence may evolve from niche innovator to industry standard-setter, redefining "authentic" leather and inspiring cross-sector biotech applications—ultimately delivering premium materials without planetary compromise, as pioneered by its founders' vision.[2][3]
Qorium has raised $28.0M across 2 funding rounds. Most recently, it raised $25.0M Series A in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2025 | $25.0M Series A | Brightlands Venture Partners, Soffinova Partners | |
| Jul 1, 2021 | $3.0M Seed | Brightlands Venture Partners |